Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.23.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance at Dec. 31, 2021 $ 2 $ 267,609 $ (250,416) $ 17,195
Beginning balance, shares at Dec. 31, 2021 77 247,105      
Stock based compensation 102 102
Stock based compensation, shares   30      
Net income (loss) (2,845) (2,845)
Ending balance at Mar. 31, 2022 $ 2 267,711 (253,261) 14,452
Ending balance, shares at Mar. 31, 2022 77 247,135      
Beginning balance at Dec. 31, 2021 $ 2 267,609 (250,416) 17,195
Beginning balance, shares at Dec. 31, 2021 77 247,105      
Net income (loss)         $ (5,357)
Issuance of common stock from the cashless exercise of warrants, shares        
Ending balance at Jun. 30, 2022 $ 2 267,821 (255,773) $ 12,050
Ending balance, shares at Jun. 30, 2022 77 247,195      
Beginning balance at Mar. 31, 2022 $ 2 267,711 (253,261) 14,452
Beginning balance, shares at Mar. 31, 2022 77 247,135      
Stock based compensation 88 88
Stock based compensation, shares   60      
Net income (loss) (2,512) (2,512)
Acquisition of subsidiary 22 22
Ending balance at Jun. 30, 2022 $ 2 267,821 (255,773) 12,050
Ending balance, shares at Jun. 30, 2022 77 247,195      
Beginning balance at Dec. 31, 2022 $ 5 268,154 (262,455) 5,704
Beginning balance, shares at Dec. 31, 2022 283 542,145      
Stock based compensation 86 86
Stock based compensation, shares   15      
Net income (loss) (293) (293)
Common stock issued for cash, net of cash fees $ 20 4,437 4,457
Common stock issued for cash, net of cash fees, shares   1,980,000      
Prefunded warrants issued for cash, net of cash fees 383 383
Extinguishment of derivative liability upon exercise of warrant 5,502 5,502
Issuance of common stock from the exercise of prefunded warrants for cash $ 2 (2)
Issuance of common stock from the exercise of prefunded warrants for cash, shares   170,000      
Issuance of common stock from the cashless exercise of warrants $ 13 (13)
Issuance of common stock from the cashless exercise of warrants, shares   1,337,600      
Redemption of preferred stock (2) (2)
Redemption of preferred stock, shares (1)        
Issuance of agent warrants 108 108
Round up shares issued in reverse split
Round up shares issued in reverse split, shares   20,475      
Ending balance at Mar. 31, 2023 $ 40 278,653 (262,748) 15,945
Ending balance, shares at Mar. 31, 2023 282 4,040,235      
Beginning balance at Dec. 31, 2022 $ 5 268,154 (262,455) 5,704
Beginning balance, shares at Dec. 31, 2022 283 542,145      
Net income (loss)         $ (2,748)
Issuance of common stock from the cashless exercise of warrants, shares        
Ending balance at Jun. 30, 2023 $ 42 278,973 (265,203) $ 13,812
Ending balance, shares at Jun. 30, 2023 256 4,208,027      
Beginning balance at Mar. 31, 2023 $ 40 278,653 (262,748) 15,945
Beginning balance, shares at Mar. 31, 2023 282 4,040,235      
Stock based compensation 71 71
Stock based compensation, shares   68      
Net income (loss) (2,455) (2,455)
Extinguishment of derivative liability upon exercise of warrant 251 251
Issuance of common stock from the cashless exercise of warrants $ 2 (2)
Issuance of common stock from the cashless exercise of warrants, shares   156,000      
Issuance of common stock from the conversion of preferred stock
Issuance of common stock from conversion of preferred stock, shares (26) 1,723      
Deemed dividend related to the conversion of preferred stock (26) (26)
Deemed dividend related to the conversion of preferred stock 26 26
Ending balance at Jun. 30, 2023 $ 42 $ 278,973 $ (265,203) $ 13,812
Ending balance, shares at Jun. 30, 2023 256 4,208,027